⌘K

Home/Filings/4/0001213900-24-004996

4//SEC Filing

WILSON GLYNN 4

Accession 0001213900-24-004996

CIK 0001937993other

View on SEC.gov Company Profile

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 7:38 PM ET

Size

5.4 KB

Accession

0001213900-24-004996

Insider Transaction Report

Form 4

Period: 2024-01-18

Cadrenal Therapeutics, Inc.CVKD

Director

Transactions

Award
Stock Options
2024-01-18+70,000→ 70,000 total
Exercise: $0.94Exp: 2034-01-17→ Common Stock (70,000 underlying)

Footnotes (1)

[F1]These options vest pro rata on a monthly basis over 12 months commencing on February 1, 2024 and vesting fully on January 18, 2025.

Documents

1 file

4
ownership.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Cadrenal Therapeutics, Inc.

CIK 0001937993

Entity typeother

Related Parties

1

filerCIK 0001405625

Filing Metadata

Form type: 4
Filed: Jan 18, 7:00 PM ET
Accepted: Jan 19, 7:38 PM ET
Size: 5.4 KB

View on SEC.gov